Article info
Extended report
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities
- Correspondence to:
Dr Yusuf Yazici
515 East 72nd Street #29E, New York, NY 10021, USA; yaziciyyahoo.com
Citation
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities
Publication history
- Accepted May 9, 2004
- First published June 18, 2004.
Online issue publication
January 12, 2005
Article Versions
- Previous version (18 June 2004).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases